🇦🇹 Austria Country × Condition
diffuse large b cell lymphoma Clinical Trials in Austria
Active clinical trials for diffuse large b cell lymphoma with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇹 Austria
Active Trials in Austria (2)
NCT06830759
Recruiting
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Enrollment
700 pts
Country
🇦🇹 Austria
AbbVie
View Trial → NCT04844866 Phase 2
Recruiting
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Enrollment
213 pts
Country
🇦🇹 Austria
Miltenyi Biomedicine GmbH
View Trial → Frequently Asked Questions
How many diffuse large b cell lymphoma clinical trials are active in Austria?
There are currently 2 active clinical trials for diffuse large b cell lymphoma with sites in Austria, of which 2 are actively recruiting patients.
How can I join a diffuse large b cell lymphoma clinical trial in Austria?
To join a diffuse large b cell lymphoma clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are diffuse large b cell lymphoma trials in Austria?
Active diffuse large b cell lymphoma trials in Austria span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology